G‐cell hyperplasia of the stomach induces ECL‐cell proliferation in the pyloric glands in a paracrinal manner. (2nd March 2015)

• Record Type: Journal Article
• Authors: Kasajima, Atsuko; Fujishima, Fumiyoshi; Morikawa, Takanori; Kawasaki, Shuhei; Konosu‐Fukaya, Sachiko; Shibahara, Yukiko; Nakamura, Tadaho; Yoshikawa, Takeo; Iijima, Katsunori; Koike, Tomoyuki; Watanabe, Mika; Shibata, Chikashi; Sasano, Hironobu
• Is Part Of: Pathology international. Volume 65:Number 5(2015:May)
• Page Start: 259
• Page End: 263
• Publication Date: 2015-03-02
• Subjects: Pathology -- Periodicals; 616.07
• DOI: 10.1111/pin.12276
• Languages: English
• ISSNs: 1320-5463

Abstract

<abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <p>An inhibitory mechanism toward gastrin hypersecretion is significantly different between G‐cell hyperplasia and gastrinoma despite the common clinical manifestations; hypergastrinemia and its related persistent gastric ulcers. We recenlty studied the G‐cell, <sc>d</sc>‐cell and ECL‐cell density in a case of G‐cell hyperplasia. The 70‐year‐old patient has been treated for persistent gastric ulcers with a markedly increased plasma gastrin (5600 pg/mL). The stomach was surgically resected because of the obstruction associated with ulcer scars. The number of G‐cells in the pyloric glands was quantified on the surgical specimens and G‐cell hyperplasia was histolopathologically identified. Immunostainig of histidine decarboxylate revealed the presence of ECL‐cell hyperplasia in the pyloric glands and its density was significantly and positively correlated with G‐cell density. Somatostatin immunoreactive cells (<sc>d</sc>‐cells) increased in their number in the oxyntic glands. These results all indicated that hypersecretion of gastrin in G‐cell hyperplasia could induce ECL‐cell proliferation in a paracrinal manner. In addition, relatively non‐prominent endocrinological features in the G‐cell hyperplasia compared to gastrinoma could be also related to the paracrinal somatostatin inhibitory effects upon ECL‐cells in the pyloric glands.</p> </abstract>